ScholarLens Back to search
2014•Unpublished venueRequires access

Marginal Zone Lymphoma

Sarah C. Rutherford, Wayne Tam, Peter Martin

Open publisher page 0 citations

Abstract

This chapter presents a series of questions and answers on marginal zone lymphoma (MZL). It commences with a discourse on how MZL is distinguished from other non-Hodgkin's lymphomas (NHLs), and ends with the discussion on the role of maintenance rituximab. The chapter also discusses on the types of MZL, the role of splenectomy in Splenic MZL (SMZL), the best treatment for localized mucosa-associated lymphoid tissue (MALT) lymphoma, and the optimal first-line treatment for advanced stage nodal MZL (NMZL).

About this research paper

What this paper is about

This chapter presents a series of questions and answers on marginal zone lymphoma (MZL). It commences with a discourse on how MZL is distinguished from other non-Hodgkin's lymphomas (NHLs), and ends with the discussion on the role of maintenance rituximab. The chapter also discusses on the types of MZL, the role of splenectomy in Splenic MZL (SMZL), the best treatment for localized mucosa-associated lymphoid tissue (MALT) lymphoma, and the optimal first-line treatment for advanced stage nodal MZL (NMZL).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This chapter presents a series of questions and answers on marginal zone lymphoma (MZL). It commences with a discourse on how MZL is distinguished from other non-Hodgkin's lymphomas (NHLs), and ends with the discussion on the role of maintenance rituximab. The chapter also discusses on the types of MZL, the role of splenectomy in Splenic MZL (SMZL), the best treatment for localized mucosa-associated lymphoid tissue (MALT) lymphoma, and the optimal first-line treatment for advanced stage nodal MZL (NMZL).

Key concepts: Geology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Marginal Zone Lymphoma — Research Paper | ScholarLens